论文部分内容阅读
目的探讨肝癌的三维适形放疗治疗原发性肝癌的临床效果。方法 50例原发性肝癌患者,随机分为研究组与对照组,每组25例。研究组给予三维适形放疗治疗,对照组给予常规放疗治疗。分析比较两组患者治疗后的临床效果。结果研究组患者的1、2、3年生存率均高于对照组,差异均有统计学意义(P<0.05)。研究组患者的总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论肝癌的三维适形放疗治疗原发性肝癌,能够提升患者的生存率和总有效率,值得临床推广。
Objective To investigate the clinical effect of three-dimensional conformal radiotherapy for hepatocellular carcinoma (HCC) in the treatment of primary liver cancer. Methods 50 patients with primary liver cancer were randomly divided into study group and control group, with 25 cases in each group. The study group received three-dimensional conformal radiotherapy and the control group received conventional radiotherapy. Analysis and comparison of two groups of patients after treatment clinical effect. Results The 1, 2, 3-year survival rates of the study group were higher than those of the control group, with significant differences (P <0.05). The total effective rate of study group was significantly higher than that of control group, the difference was statistically significant (P <0.05). Conclusion Three-dimensional conformal radiotherapy of hepatocellular carcinoma for the treatment of primary liver cancer can improve the survival rate and total effective rate of patients, which is worthy of clinical promotion.